Evidence map›Paper›PMID 37191680›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

GCP III is not the "off-target" for urea-based PSMA ligands.

Zhenghong Lee, Warren D Heston, Xinning Wang, James P Basilion

Abstract readLetterComment
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. JHU-2545 preferentially shields salivary glands and kidneys during PSMA-targeted imaging.European journal of nuclear medicine and molecular imaging · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synthesis and Evaluation ofMolecules (Basel, Switzerland) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Zhenghong LeeRadiology, School of Medicine, Case Western Reserve University, Nuclear Medicine, Radiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH, 44106, USA. ZXL11@case.edu.ORCID 0000-0002-2429-9911
Warren D HestonCancer Biology, Cleveland Clinic, Cleveland, OH, 44195, USA.
Xinning WangRadiology, School of Medicine, Case Western Reserve University, Nuclear Medicine, Radiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH, 44106, USA.
James P BasilionRadiology, School of Medicine, Case Western Reserve University, Nuclear Medicine, Radiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH, 44106, USA.

Funding

Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmuR01CA269816 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SUSANN M BRADY-KALNAY, James Peter Basilion · 2023 to 2026
$2.6M
NCI NIH HHS R01 CA269816
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Glutamate Carboxypeptidase IIUreaAntigens, SurfaceCell Line, TumorHumansLigandsAntigens, SurfaceGlutamate Carboxypeptidase IILigandsUrea

Identifiers

PMID37191680
PMCPMC10382371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.